KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 0.09%.

  • AbbVie's Return on Capital Employed fell 400.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.09% for FY2024, which is 300.0% down from last year.
  • AbbVie's Return on Capital Employed amounted to 0.09% in Q3 2025, which was down 400.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Return on Capital Employed registered a high of 0.17% during Q2 2023, and its lowest value of 0.09% during Q4 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.14% (2021), whereas its average is 0.13%.
  • Over the last 5 years, AbbVie's Return on Capital Employed had its largest YoY gain of 700bps in 2021, and its largest YoY loss of -800bps in 2021.
  • Quarter analysis of 5 years shows AbbVie's Return on Capital Employed stood at 0.16% in 2021, then increased by 3bps to 0.16% in 2022, then decreased by -20bps to 0.13% in 2023, then tumbled by -30bps to 0.09% in 2024, then increased by 3bps to 0.09% in 2025.
  • Its Return on Capital Employed stands at 0.09% for Q3 2025, versus 0.11% for Q2 2025 and 0.1% for Q1 2025.